FDA product code PGX: Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System

PGX is the FDA product code for groups a, c and g beta-hemolytic streptococcus nucleic acid amplification system. It is a Class II device, regulated under 21 CFR 866.2680 and reviewed by the Microbiology panel. FDA has cleared 14 510(k) submissions under PGX, 2 in the last five years, from 10 different applicants. The average 510(k) review took 135 days (median 112); 183 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 4 recalls for PGX devices, 2 initiated in the last five years.

Definition

An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.

Classification

FieldValue
Device nameGroups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
Device classClass II
Regulation21 CFR 866.2680
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

510(k) clearances per year for PGX

YearClearancesAvg. review days
2017278
20182166
2019192
20201181
20262183

Compare with all 510(k) review times · Search every PGX clearance

Top PGX applicants

ApplicantClearancesLatest
Quidel Corporation32016-10-25
Alere Scarborough, Inc.22018-05-02
Cepheid22018-04-26
Roche Molecular Systems, Inc.12026-08-28
Diasorin Molecular, LLC12026-06-15

5 more applicants have PGX clearances. See the full list in Caduvo.

Most recent PGX clearances

510(k)ApplicantDeviceDecision dateReview days
K260047Roche Molecular Systems, Inc.cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190); cobas Strep A Quality Control Kit (07402678190)2026-08-28233
K260333Diasorin Molecular, LLCLIAISON NES Group A Strep; LIAISON NES Group A Strep Control Swab Kit2026-06-15133
K201269Mesa Biotech, Inc.Accula Strep A Test2020-11-09181
K183366Genepoc, Inc.GenePOC Strep A2019-03-0692
K173653Alere Scarborough, Inc.Alere i Strep A 2, Alere i instrument, Alere i Strep A 2 Control Swab Kit2018-05-02155

Recalls for PGX devices

4 product recalls in 3 recall events; 2 initiated in the last five years and 3 still open. Most recent: 2023-04-24.

YearRecalls
20191
20232

Frequently asked questions

What is FDA product code PGX?

PGX is the FDA product code for groups a, c and g beta-hemolytic streptococcus nucleic acid amplification system. It is a Class II device, regulated under 21 CFR 866.2680 and reviewed by the Microbiology panel.

What device class is PGX?

Class II, regulation 21 CFR 866.2680. Typical premarket route: 510(k).

How long does a 510(k) take for product code PGX?

Across 14 cleared submissions the average was 135 days from receipt to decision (median 112).

Which companies have the most PGX clearances?

Quidel Corporation (3); Alere Scarborough, Inc. (2); Cepheid (2); Roche Molecular Systems, Inc. (1); Diasorin Molecular, LLC (1).

Have PGX devices been recalled?

Yes: 4 product recalls across 3 recall events; the most recent began 2023-04-24.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times